Minneapolis, Minnesota, United States In 2004 was created SightLine Partners, which is appeared as VC. The main department of described VC is located in the Minneapolis. The venture was found in North America in United States.
Among the most successful fund investment fields, there are Medical, Life Science. Among the most popular portfolio startups of the fund, we may highlight CVRx, EndoGastric Solutions, Earlens Corporation. The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 11-15 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The fund was created by Heath Lukatch. We also calculated 2 valuable employees in our database.
The increased amount of exits for fund were in 2015. The fund is constantly included in less than 2 deals per year. The real fund results show that this VC is 10 percentage points less often commits exit comparing to other companies. The top activity for fund was in 2006. Despite it in 2019 the fund had an activity. This SightLine Partners works on 4 percentage points less the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the SightLine Partners, startups are often financed by QuestMark Partners, Piper Jaffray, New Enterprise Associates. The meaningful sponsors for the fund in investment in the same round are New Enterprise Associates, Affinity Capital Management, Split Rock Partners. In the next rounds fund is usually obtained by New Enterprise Associates, Perceptive Advisors, Morgenthaler Ventures.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Bingshen Investment | China, Guangdong, Shenzhen |
| CfC Stanbic Bank | Kenya, Nairobi, Nairobi Area |
| China Comservice Capital | - |
| EnergyFunders | Houston, Texas, United States |
| Fides Finanz-Invest | Germany, Schleswig-Holstein, Timmendorfer Strand |
| Huron Group | California, Los Angeles, United States |
| Lawson | Japan, Tokyo |
| MFV Partners | California, Palo Alto, United States |
| Obvious Ventures | California, San Francisco, United States |
| Reinsurance Group Of America | Chesterfield, Missouri, United States |
| Shanxi Qingchuang Zhongbang Network Technology | China, Fujian, Shanxi |
| TH Capital | Kuala Lumpur, Malaysia |
| TIBCORP | Central, Central Region, Singapore |
| TKS1 | - |
| Tristel | Cambridgeshire, Snailwell, United Kingdom |
| Utrust VC | - |
| YG Entertainment | Seoul, Seoul-t'ukpyolsi, South Korea |
| Yintaihuaying | Beijing, Beijing Shi, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Magnolia Medical Technologies | $20M | 30 Jan 2019 | Seattle, Washington, United States | ||
Earlens Corporation | $73M | 05 Jun 2017 | California, United States | ||
Monteris Medical | $26M | 01 Jun 2017 | Minnesota, United States | ||
Vapotherm | $20M | 13 Jul 2015 | New Hampshire, United States | ||
Conventus Orthopaedics | $24M | 02 Dec 2014 | Minnesota, United States | ||
Anulex Technologies | $20M | 25 Jul 2006 | Minnesota, United States | ||
Verax Biomedical | $15M | 14 Oct 2005 | Marlborough, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Magnolia Medical Technologies | $20M | 30 Jan 2019 | Seattle, Washington, United States | ||
Earlens Corporation | $73M | 05 Jun 2017 | California, United States | ||
Monteris Medical | $26M | 01 Jun 2017 | Minnesota, United States | ||
Vapotherm | $20M | 13 Jul 2015 | New Hampshire, United States | ||
Conventus Orthopaedics | $24M | 02 Dec 2014 | Minnesota, United States | ||
Anulex Technologies | $20M | 25 Jul 2006 | Minnesota, United States | ||
Verax Biomedical | $15M | 14 Oct 2005 | Marlborough, Massachusetts, United States |
